Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    August 2022
  1. KAEHLER M, Litterst M, Kolarova J, Bohm R, et al
    Genomewide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitorresistant CML cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available

    June 2022
  2. LALIC H, Aurer I, Batinic D, Visnjic D, et al
    Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    May 2022
  3. FORGIONE MO, McClure BJ, Page EC, Yeung DT, et al
    TP53 lossoffunction mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    April 2022
  4. LI Z, Zhang J, Zhou M, Li JL, et al
    Epigenetic therapy with chidamide alone or combined with 5azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    February 2022
  5. HUANG FL, Yu SJ, Liao EC, Li LY, et al
    Niclosamide suppresses Tcell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    January 2022
  6. LIANG X, Xia R
    Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    October 2021
  7. AYE KT, Wattanapongpitak S, Supawat B, Kothan S, et al
    Gallic acid enhances pirarubicininduced anticancer in living K562 and K562/Dox leukemia cancer cells through cellular energetic state impairment and Pglycoprotein inhibition.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    July 2021
  8. YAO J, Luo Y, Zeng C, He H, et al
    UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

  9. SHI YF, Huang ZY, Huang YS, Dong RJ, et al
    Interaction between CD9 and PI3Kp85 activates the PI3K/AKT signaling pathway in Blineage acute lymphoblastic leukemia.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

  10. LIU YH, Zhu M, Lei PP, Pan XY, et al
    ND09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCRABL signaling.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

  11. FU JF, Shih LY, Yen TH
    HOXA11 plays critical roles in disease progression and response to cytarabine in AML.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    June 2021
  12. DONG L, Xu WW, Li H, Bi KH, et al
    [Retracted] In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrialmediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
    Oncol Rep. 2021;45.
    PubMed     Abstract available

  13. GENG Y, Wu W, Zhou L, Li J, et al
    Synergistic effects of LY294002 and ABT199 on the cell cycle in K562, HL60 and KG1a cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available

    April 2021
  14. JIANG H, Tang J, Qiu L, Zhang Z, et al
    Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

  15. ZHOU H, Ning Y, Zeng G, Zhou C, et al
    Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

    March 2021
  16. JING W, Zhou M, Chen R, Ye X, et al
    In vitro and ex vivo antitumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2overexpressing leukemia cells.
    Oncol Rep. 2021;45:1142-1152.
    PubMed     Abstract available

    February 2021
  17. ZHANG P, Wang Y, Qin M, Li D, et al
    Involvement of Blnk and Foxo1 in tumor suppression in BCRABL1transformed proB cells.
    Oncol Rep. 2021;45:693-705.
    PubMed     Abstract available

    January 2021
  18. GONG Y, Deng J, Wu X
    Germline mutations and blood malignancy (Review).
    Oncol Rep. 2021;45:49-57.
    PubMed     Abstract available

    November 2020
  19. MEI S, Zhang Y, Yu L, Chen G, et al
    Expression and role of fibroblast activation protein alpha in acute myeloid leukemia.
    Oncol Rep. 2020 Nov 30. doi: 10.3892/or.2020.7874.
    PubMed     Abstract available

  20. ZHANG H, Wang Y, Yang H, Huang Z, et al
    TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/betacatenin/TCF7/ABC transporter signaling axis.
    Oncol Rep. 2020 Nov 27. doi: 10.3892/or.2020.7869.
    PubMed     Abstract available

  21. TAKEDA T, Tsubaki M, Genno S, Nemoto C, et al
    AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitorsensitive and resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora B.
    Oncol Rep. 2020;44:2211-2218.
    PubMed     Abstract available

    September 2020
  22. XU W, Huang Z, Gan Y, Chen R, et al
    Casein kinase 1alpha inhibits p53 downstream of MDM2mediated autophagy and apoptosis in acute myeloid leukemia.
    Oncol Rep. 2020 Sep 9. doi: 10.3892/or.2020.7760.
    PubMed     Abstract available

  23. FAN Z, Luo H, Zhou J, Wang F, et al
    Checkpoint kinase1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7757.
    PubMed     Abstract available

    August 2020
  24. WANG T, Du J, Kong D, Yang G, et al
    Gambogic acid inhibits proliferation and induces apoptosis of human acute Tcell leukemia cells by inducing autophagy and downregulating betacatenin signaling pathway: Mechanisms underlying the effect of Gambogic acid on TALL cells.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7726.
    PubMed     Abstract available

  25. NAPOLITANO R, De Matteis S, Carloni S, Bruno S, et al
    Kevetrin induces apoptosis in TP53 wildtype and mutant acute myeloid leukemia cells.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7730.
    PubMed     Abstract available

  26. XU Y, Lin Y, Luo Y, Yang Y, et al
    RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2deficient human acute myeloid leukemia.
    Oncol Rep. 2020 Aug 10. doi: 10.3892/or.2020.7723.
    PubMed     Abstract available

  27. DONG A, Yang W, Huang H, Zhou X, et al
    Bioinformatics analysis of the network of histone H3 lysine 9 trimethylation in acute myeloid leukaemia.
    Oncol Rep. 2020;44:543-554.
    PubMed     Abstract available

    July 2020
  28. JIN J, Li X, Guo W, Li F, et al
    Novel SAHAbendamustine hybrid NL101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia.
    Oncol Rep. 2020;44:273-282.
    PubMed     Abstract available

  29. PUENTE-MONCADA N, Turos-Cabal M, Sanchez-Sanchez AM, Antolin I, et al
    Role of glucose metabolism in the differential antileukemic effect of melatonin on wildtype and FLT3ITD mutant cells.
    Oncol Rep. 2020;44:293-302.
    PubMed     Abstract available

    February 2020
  30. XIONG Q, Huang S, Li YH, Lv N, et al
    Singlecell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction.
    Oncol Rep. 2020 Feb 18. doi: 10.3892/or.2020.7507.
    PubMed     Abstract available

    January 2020
  31. LI S, Bo Z, Jiang Y, Song X, et al
    Homoharringtonine promotes BCRABL degradation through the p62mediated autophagy pathway.
    Oncol Rep. 2020;43:113-120.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.